Building Networks to Excel in Glycoscience
A capacity-building network with the ambitious goal to provide a breakthrough in the research of UCIBIO-NovaFCT
Science
Glycoscience in cancer treatment:
monoclonal antibodies
GLYCOTwinning brings synergy and multidisciplinarity in cutting-edge scientific methodologies: glycan microarrays, advanced electrophoresis, High-Resolution Mass Spectrometry and Nuclear Magnetic Resonance, to decode sugar recognition by glycan-binding proteins involved in disease.
Through GLYCOTwinning, UCIBIO-NOVA will reinforce its research capacity, expanding its current R&D+I profile to dissect glycan-protein interactions, from the atomic and molecular levels to the cellular context, boosting the development of innovative glycan-based tools, diagnosis, and therapies.
Furthermore, GLYCOTwinning will integrate its objectives in a project that explores glycan-protein interactions of the human microbiome in colorectal cancer, validating a GLYCOTwinning ToolBox, creating new knowledge, innovation and opening new research avenues for the widest dissemination and exploitation, with long term scientific and societal impact.
Events
Workshop Grant Writing
19 September 2025
3rd Joint Lab Retreat
17-18 September 2025
11-12 September 2025
Guest seminar
11 November 2025
Elena Laugieri, in the context of CIC bioGUNE partner expert visit, will give a seminar entitled “Blocking the lectin–glycan Axis to Restore Anti-Tumor Immunity”.
Staff Exchange at Imperial College of London
9-12 November
Teresa Sequeira Carlos, as Head of Science Communication and Management Office at UCIBIO - I4HB, engaged with several strategic units at Imperial, including: Communications & Web Team and the Research Strategy Team - Imperial Medicine;Early Career Researcher Institute (ECRI) .
News
19 September 2025
18 September 2025
15-17 September 2025
Workshop on SciComm and Public Engagement
11-12 September 2025
Newsletters
26 November 2025
Society for Glycobiology Annual Meeting
9-12 November
Angelina Palma, coordinator of GLYCOTwinning, and Ana Benavente, PhD candidate at GlycoLab (UCIBIO-NOVA FCT), as well as other GLYCOTwinning Consortium partner leaders and researchers, were present at the 2025 Meeting of the Society for Glycobiology, which took place in San Diego, USA.
29 October 2025
The latest work of Glycoimmunology Lab (Paula Videira) explores how cancer-associated O-glycans interact with the gut microbiome in colorectal cancer. The article, entitled Cancer-associated O-glycans and microbiome interactions in colorectal cancer: insights into tumor progression and immune evasion, has been published on Journal of Cancer Metastasis and Treatment.
Project
GLYCOTwinning is a capacity-building network with the ambitious goal to provide a breakthrough in the research of the Applied Biomolecular Sciences Unit, NOVA University Lisbon (UCIBIO-NOVA), from chemistry to microbiology, immunology and biomedicine. To achieve excellence, UCIBIO-NOVA needs further synergies, to be acquired through networking with topclass partners: Imperial College, LUMC and CICbioGUNE.
Objectives
Promote scientific excellence and innovation in Glycoscience;
Empower researchers’ capacity and creativity;
Strengthen research management and administration skills;
Raise dissemination activities;
Boost reputation, research profile and attractiveness.